The number of patients with acute episodes of severe bronchospasm needing intubation and ventilatory support has increased rapidly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease 2019 (COVID-19) pandemic. Although medical consensus upholds the use of ventilatory support in this pathology, its survival benefits remain unclear. To improve the outcomes and survival rates, a bundle of early respiratory therapy with a pharmacological rescue regimen was provided to four patients with bronchospasm secondary to COVID-19. This therapeutic approach successfully delayed the need for invasive mechanical ventilation for 48 hours and decreased the mortality rate in all cases.
【저자키워드】 COVID-19 outbreak, Invasive mechanical ventilation, COVID-19 management, 【초록키워드】 COVID-19, pathology, coronavirus, pandemic, therapy, intubation, outcome, survival, Patient, mortality rate, disease, Therapeutic approach, regimen, ventilatory support, Consensus, acute respiratory syndrome, survival rates, pharmacological, benefit, IMPROVE, provided, 48 hour, 【제목키워드】 bronchospasm, Decreased, Mechanical,